{"id":354471,"date":"2025-08-28T12:03:42","date_gmt":"2025-08-28T12:03:42","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-myriad-genetics\/"},"modified":"2025-08-28T12:03:42","modified_gmt":"2025-08-28T12:03:42","slug":"how-to-buy-myriad-genetics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/","title":{"rendered":"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354471","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Myriad Genetics (MYGN) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Myriad Genetics (MYGN) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin."},"intro":"Genetik test yenili\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Myriad Genetics (MYGN), hem heyecan verici potansiyel hem de \u00f6nemli riskler ta\u015f\u0131yan ileri d\u00fczey hassas t\u0131bb\u0131 temsil ediyor. Molek\u00fcler tan\u0131 y\u00f6ntemleri sa\u011fl\u0131k hizmetlerini d\u00f6n\u00fc\u015ft\u00fcr\u00fcrken, bu \u015firket benzersiz bir f\u0131rsat sunuyor\u2014ancak dikkatli bir strateji gerektiriyor. MYGN'nin portf\u00f6y\u00fcn\u00fczde olup olmamas\u0131 gerekti\u011fini ve bu volatil biyoteknoloji hissesine nas\u0131l yakla\u015fman\u0131z gerekti\u011fini birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Genetik test yenili\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Myriad Genetics (MYGN), hem heyecan verici potansiyel hem de \u00f6nemli riskler ta\u015f\u0131yan ileri d\u00fczey hassas t\u0131bb\u0131 temsil ediyor. Molek\u00fcler tan\u0131 y\u00f6ntemleri sa\u011fl\u0131k hizmetlerini d\u00f6n\u00fc\u015ft\u00fcr\u00fcrken, bu \u015firket benzersiz bir f\u0131rsat sunuyor\u2014ancak dikkatli bir strateji gerektiriyor. MYGN'nin portf\u00f6y\u00fcn\u00fczde olup olmamas\u0131 gerekti\u011fini ve bu volatil biyoteknoloji hissesine nas\u0131l yakla\u015fman\u0131z gerekti\u011fini birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Myriad Genetics Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla Myriad Genetics (MYGN) <strong>5,89 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat, hem m\u00fccadele hem de potansiyel toparlanman\u0131n dramatik bir hikayesini anlat\u0131yor. Bu, Myriad Genetics, Inc. (MYGN) hisselerini nas\u0131l alaca\u011f\u0131n\u0131 d\u00fc\u015f\u00fcnen yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir karar noktas\u0131d\u0131r.<\/p> <p><strong>Takviminize not edin: 6 Kas\u0131m 2025 kesinlikle kritik.<\/strong> Myriad'nin 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 bu tarih, hissenin seyrini dramatik \u015fekilde de\u011fi\u015ftirebilir. Tarihsel olarak, bu raporlar b\u00fcy\u00fck volatilite yarat\u0131r.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 MYGN Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>5 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>5,50 $<\/td><td><strong>%7,1 Art\u0131\u015f<\/strong> (tahminleri a\u015ft\u0131)<\/td><\/tr> <tr><td>6 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>8,20 $<\/td><td><strong>%41,3 D\u00fc\u015f\u00fc\u015f<\/strong> (gelir hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>\u015eub 2025<\/td><td>Y\u00f6nlendirme G\u00fcncellemesi<\/td><td>12,50 $<\/td><td><strong>%18,4 D\u00fc\u015f\u00fc\u015f<\/strong> (tahminler d\u00fc\u015f\u00fcr\u00fcld\u00fc)<\/td><\/tr> <tr><td>Kas 2024<\/td><td>\u00dcr\u00fcn Lansman\u0131<\/td><td>14,80 $<\/td><td><strong>%3,2 Art\u0131\u015f<\/strong> (\u0131l\u0131ml\u0131 kazan\u00e7)<\/td><\/tr> <tr><td>A\u011fu 2024<\/td><td>2. \u00c7eyrek 2024<\/td><td>15,20 $<\/td><td><strong>%5,8 D\u00fc\u015f\u00fc\u015f<\/strong> (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td><\/tr> <tr><td>May 2024<\/td><td>Y\u0131ll\u0131k Toplant\u0131<\/td><td>16,50 $<\/td><td><strong>%2,1 Art\u0131\u015f<\/strong> (istikrarl\u0131)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Analizi<\/strong>: MYGN, kazan\u00e7 s\u00fcrprizlerine \u015fiddetle tepki verir. May\u0131s 2025 \u00e7\u00f6k\u00fc\u015f\u00fc k\u00f6t\u00fc haberlerin hisseyi nas\u0131l y\u0131kt\u0131\u011f\u0131n\u0131 g\u00f6sterirken, A\u011fustos'taki son kazan\u00e7 art\u0131\u015f\u0131 g\u00fczel bir y\u00fckseli\u015f yaratt\u0131. Bu model, Myriad Genetics, Inc. (MYGN) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 \u00f6\u011frenen herkes i\u00e7in zamanlamay\u0131 kesinlikle kritik k\u0131lar.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Krizden Umuda<\/h2> <p>Myriad'nin hissesi Mart'tan A\u011fustos 2025'e kadar bir h\u0131z treni gibiydi:<\/p> <p><strong>Ocak 2025<\/strong>: 12,04 $-15,08 $ (iyimser ba\u015flang\u0131\u00e7)<br\/> <strong>\u015eubat 2025<\/strong>: 9,76 $-15,47 $ (erken uyar\u0131 i\u015faretleri)<br\/> <strong>Mart 2025<\/strong>: 8,53 $-11,44 $ (istikrarl\u0131 d\u00fc\u015f\u00fc\u015f ba\u015fl\u0131yor)<br\/> <strong>Nisan 2025<\/strong>: 7,11 $-8,97 $ (endi\u015feler h\u0131zlan\u0131yor)<br\/> <strong>May\u0131s 2025<\/strong>: 3,81 $-7,81 $ (<strong>%41,57 \u00c7\u00f6k\u00fc\u015f<\/strong> - UnitedHealthcare felaketi)<br\/> <strong>Haziran-A\u011fustos 2025<\/strong>: 4,20 $-6,50 $ (stabilizasyon ve toparlanma)<\/p> <p>Genel alt\u0131 ayl\u0131k performans, Ocak zirvesinden itibaren y\u0131k\u0131c\u0131 bir <strong>%61 d\u00fc\u015f\u00fc\u015f<\/strong> g\u00f6steriyor, ancak son aylar 5,00 $-6,00 $ seviyelerinde potansiyel dip i\u015faretleri veriyor.<\/p> <p><strong>Neden bu kadar a\u015f\u0131r\u0131 volatilite?<\/strong><\/p> <ul> <li>UnitedHealthcare GeneSight kapsam\u0131n\u0131 kesti (gelirin %20'si darbe ald\u0131)<\/li> <li>Menkul k\u0131ymetler doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 soru\u015fturmas\u0131 duyurusu<\/li> <li>Negatif nakit ak\u0131\u015f\u0131 endi\u015feleri<\/li> <li>Son 2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi umut \u0131\u015f\u0131\u011f\u0131 g\u00f6steriyor<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p><strong>2025 Y\u0131l Sonu<\/strong>: 8,00 $-11,00 $ \u2192 <strong>D\u0130KKATL\u0130 ALIM<\/strong><br\/> 3. ve 4. \u00e7eyrek iyile\u015fme g\u00f6sterirse, analist hedeflerine do\u011fru bir y\u00fckseli\u015f g\u00f6rebiliriz. Son kredi imkan\u0131 nefes ald\u0131r\u0131yor.<\/p> <p><strong>2026 Projeksiyonu<\/strong>: 12,00 $-18,00 $<br\/> Onkoloji geni\u015flemesinin ba\u015far\u0131l\u0131 olmas\u0131 ve yasal sorunlar\u0131n \u00e7\u00f6z\u00fclmesi durumunda \u0131l\u0131ml\u0131 bir toparlanma m\u00fcmk\u00fcn g\u00f6r\u00fcn\u00fcyor.<\/p> <p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 15,00 $-25,00 $<br\/> Uzun vadede kanser testi benimsenmesi ve yeni \u00fcr\u00fcn lansmanlar\u0131na ba\u011fl\u0131. Hassas t\u0131p pazar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde b\u00fcy\u00fcmeli.<\/p> <p><strong>2030 Vizyonu<\/strong>: 20,00 $-30,00 $<br\/> Myriad kal\u0131tsal kanser testlerinde lider olur ve uluslararas\u0131 alanda geni\u015flerse, \u00f6nemli bir yukar\u0131 potansiyel var.<\/p> <p><strong>Karar<\/strong>: Sadece risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in. Mevcut fiyat potansiyel y\u00fckseli\u015f sunuyor, ancak bir\u00e7ok zorluk devam ediyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon kabusu<\/strong>: UnitedHealthcare kapsam kesintileri di\u011fer sigortac\u0131lara yay\u0131labilir<\/li> <li><strong>Mali stres<\/strong>: Negatif i\u015fletme nakit ak\u0131\u015f\u0131 (son \u00e7eyrekte 16,3 milyon $) ve devam eden zararlar<\/li> <li><strong>Hukuki belirsizlik<\/strong>: Menkul k\u0131ymetler doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 soru\u015fturmas\u0131 belirsizlik ve potansiyel y\u00fck\u00fcml\u00fcl\u00fckler yarat\u0131yor<\/li> <li><strong>A\u015f\u0131r\u0131 volatilite<\/strong>: G\u00fcnl\u00fck %6,44 dalgalanmalar sinirli yat\u0131r\u0131mc\u0131lar i\u00e7in uygun de\u011fil<\/li> <li><strong>Rekabet<\/strong>: Daha iyi teknolojiye sahip yeni genetik test \u015firketleri ortaya \u00e7\u0131k\u0131yor<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi<\/strong>: 213,1 milyon $ gelir tahminleri %5,6 a\u015ft\u0131 (<a href=\"https:\/\/www.nasdaq.com\/articles\/myriad-genetics-mygn-q2-revenue-6\">Nasdaq Raporu<\/a>)<\/li> <li><strong>Yeni 200 milyon $ kredi imkan\u0131<\/strong>: Kritik finansal esneklik sa\u011fl\u0131yor (<a href=\"https:\/\/investor.myriad.com\/news-releases\/news-release-detail\/26541\/\">\u015eirket Duyurusu<\/a>)<\/li> <li><strong>Br\u00fct kar marj\u0131 geni\u015flemesi<\/strong>: %71,2'ye y\u00fckselerek operasyonel verimlilik g\u00f6steriyor<\/li> <li><strong>Kanser testi geni\u015flemesi<\/strong>: MyRisk kal\u0131tsal kanser testi ilgi g\u00f6r\u00fcyor<\/li> <li><strong>EMR entegrasyonu<\/strong>: Epic ve Flatiron sistemleri ile \u00e7al\u0131\u015f\u0131yor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Kas\u0131m kazan\u00e7lar\u0131n\u0131 bekleyin<\/strong>: 6 Kas\u0131m raporu netlik sa\u011flayacak\u2014k\u00f6r\u00fc k\u00f6r\u00fcne atlamay\u0131n<\/li> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Al\u0131m yaparsan\u0131z, portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3'\u00fcnden fazlas\u0131n\u0131 bu y\u00fcksek riskli i\u015fe ay\u0131rmay\u0131n<\/li> <li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong>: Bu hisse dramatik d\u00fc\u015f\u00fc\u015fler yapabilir\u2014sermayenizi koruyun<\/li> <li><strong>\u00c7e\u015fitlendirin<\/strong>: T\u00fcm biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131z\u0131 tek sepete koymay\u0131n<\/li> <\/ol> <p><strong>Mizahi not<\/strong>: \"MYGN ticareti genetik test gibi\u2014bazen beklenmedik \u00f6zellikler ke\u015ffedersiniz... mesela hesab\u0131n\u0131z\u0131n ne kadar h\u0131zl\u0131 a\u015fa\u011f\u0131 mutasyona u\u011frayabilece\u011fi!\"<\/p> <h2>\u2705 Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ hisselerini sunan ve rekabet\u00e7i \u00fccretlere sahip oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Risk edebilece\u011finiz k\u00fc\u00e7\u00fck bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>MYGN'yi kapsaml\u0131 ara\u015ft\u0131r\u0131n<\/td><td>Sadece g\u00fcncel fiyat\u0131n \u00f6tesindeki riskleri anlay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Limit emirleri kullan\u0131n<\/td><td>A\u015f\u0131r\u0131 \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td><\/tr> <tr><td>5<\/td><td>Pozisyonu yak\u0131ndan takip edin<\/td><td>Bu hisse aktif y\u00f6netim gerektirir, unutup b\u0131rakmak uygun de\u011fil<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option MYGN Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>Myriad Genetics, Inc. (MYGN) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 d\u00fc\u015f\u00fcnenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - MYGN gibi y\u00fcksek riskli hisselerle strateji test etmek i\u00e7in ideal<\/li> <li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> - F\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda h\u0131zl\u0131ca ticarete ba\u015flay\u0131n<\/li> <li><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> - Kar almay\u0131 veya zarar\u0131 h\u0131zl\u0131 kesmeyi esnek hale getirir<\/li> <li><strong>Ger\u00e7ek zamanl\u0131 NASDAQ verisi<\/strong> - Volatil biyoteknoloji hisselerinin zamanlamas\u0131 i\u00e7in vazge\u00e7ilmez<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, b\u00fcy\u00fck sermaye taahh\u00fct etmeden MYGN gibi spek\u00fclatif hisselere maruz kalmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Myriad Genetics: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2> <p>Myriad Genetics, sa\u011fl\u0131k inovasyonu ile finansal zorluklar\u0131n kesi\u015fim noktas\u0131nda duruyor. \u015eirket, kanser risklerini tespit etmeye ve tedavi kararlar\u0131n\u0131 y\u00f6nlendirmeye yard\u0131mc\u0131 olan molek\u00fcler tan\u0131 testlerinde uzmanla\u015fm\u0131\u015ft\u0131r ve bir\u00e7ok t\u0131bbi uzmanl\u0131k alan\u0131nda hizmet vermektedir.<\/p> <p><strong>Mevcut Pazar Konumu<\/strong>: Son zorluklara ra\u011fmen, Myriad genetik testlerde \u00f6nemli bir oyuncu olmaya devam ediyor:<\/p> <ul> <li>\u00d6nde gelen kal\u0131tsal kanser risk de\u011ferlendirme teknolojisi<\/li> <li>B\u00fcy\u00fcyen prenatal test segmenti (son \u00e7eyrekte %11 art\u0131\u015f)<\/li> <li>Geni\u015fleyen elektronik t\u0131bbi kay\u0131t entegrasyonu<\/li> <li>200 milyon $ kredi imkan\u0131 ile operasyonel s\u00fcreklilik<\/li> <\/ul> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Myriad'nin SneakPeek Erken Cinsiyet DNA Testi yak\u0131n zamanda <strong>bir milyonuncu m\u00fc\u015fterisine<\/strong> sonu\u00e7 verdi\u2014sa\u011fl\u0131k geri \u00f6deme zorluklar\u0131na ra\u011fmen genetik i\u00e7g\u00f6r\u00fclere olan t\u00fcketici talebinin b\u00fcy\u00fcmeye devam etti\u011fini kan\u0131tl\u0131yor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Myriad Genetics Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla Myriad Genetics (MYGN) <strong>5,89 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat, hem m\u00fccadele hem de potansiyel toparlanman\u0131n dramatik bir hikayesini anlat\u0131yor. Bu, Myriad Genetics, Inc. (MYGN) hisselerini nas\u0131l alaca\u011f\u0131n\u0131 d\u00fc\u015f\u00fcnen yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir karar noktas\u0131d\u0131r.<\/p>\n<p><strong>Takviminize not edin: 6 Kas\u0131m 2025 kesinlikle kritik.<\/strong> Myriad&#8217;nin 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 bu tarih, hissenin seyrini dramatik \u015fekilde de\u011fi\u015ftirebilir. Tarihsel olarak, bu raporlar b\u00fcy\u00fck volatilite yarat\u0131r.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 MYGN Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>5 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>5,50 $<\/td>\n<td><strong>%7,1 Art\u0131\u015f<\/strong> (tahminleri a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>6 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>8,20 $<\/td>\n<td><strong>%41,3 D\u00fc\u015f\u00fc\u015f<\/strong> (gelir hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>\u015eub 2025<\/td>\n<td>Y\u00f6nlendirme G\u00fcncellemesi<\/td>\n<td>12,50 $<\/td>\n<td><strong>%18,4 D\u00fc\u015f\u00fc\u015f<\/strong> (tahminler d\u00fc\u015f\u00fcr\u00fcld\u00fc)<\/td>\n<\/tr>\n<tr>\n<td>Kas 2024<\/td>\n<td>\u00dcr\u00fcn Lansman\u0131<\/td>\n<td>14,80 $<\/td>\n<td><strong>%3,2 Art\u0131\u015f<\/strong> (\u0131l\u0131ml\u0131 kazan\u00e7)<\/td>\n<\/tr>\n<tr>\n<td>A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek 2024<\/td>\n<td>15,20 $<\/td>\n<td><strong>%5,8 D\u00fc\u015f\u00fc\u015f<\/strong> (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td>\n<\/tr>\n<tr>\n<td>May 2024<\/td>\n<td>Y\u0131ll\u0131k Toplant\u0131<\/td>\n<td>16,50 $<\/td>\n<td><strong>%2,1 Art\u0131\u015f<\/strong> (istikrarl\u0131)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Analizi<\/strong>: MYGN, kazan\u00e7 s\u00fcrprizlerine \u015fiddetle tepki verir. May\u0131s 2025 \u00e7\u00f6k\u00fc\u015f\u00fc k\u00f6t\u00fc haberlerin hisseyi nas\u0131l y\u0131kt\u0131\u011f\u0131n\u0131 g\u00f6sterirken, A\u011fustos&#8217;taki son kazan\u00e7 art\u0131\u015f\u0131 g\u00fczel bir y\u00fckseli\u015f yaratt\u0131. Bu model, Myriad Genetics, Inc. (MYGN) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 \u00f6\u011frenen herkes i\u00e7in zamanlamay\u0131 kesinlikle kritik k\u0131lar.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Krizden Umuda<\/h2>\n<p>Myriad&#8217;nin hissesi Mart&#8217;tan A\u011fustos 2025&#8217;e kadar bir h\u0131z treni gibiydi:<\/p>\n<p><strong>Ocak 2025<\/strong>: 12,04 $-15,08 $ (iyimser ba\u015flang\u0131\u00e7)<br \/> <strong>\u015eubat 2025<\/strong>: 9,76 $-15,47 $ (erken uyar\u0131 i\u015faretleri)<br \/> <strong>Mart 2025<\/strong>: 8,53 $-11,44 $ (istikrarl\u0131 d\u00fc\u015f\u00fc\u015f ba\u015fl\u0131yor)<br \/> <strong>Nisan 2025<\/strong>: 7,11 $-8,97 $ (endi\u015feler h\u0131zlan\u0131yor)<br \/> <strong>May\u0131s 2025<\/strong>: 3,81 $-7,81 $ (<strong>%41,57 \u00c7\u00f6k\u00fc\u015f<\/strong> &#8211; UnitedHealthcare felaketi)<br \/> <strong>Haziran-A\u011fustos 2025<\/strong>: 4,20 $-6,50 $ (stabilizasyon ve toparlanma)<\/p>\n<p>Genel alt\u0131 ayl\u0131k performans, Ocak zirvesinden itibaren y\u0131k\u0131c\u0131 bir <strong>%61 d\u00fc\u015f\u00fc\u015f<\/strong> g\u00f6steriyor, ancak son aylar 5,00 $-6,00 $ seviyelerinde potansiyel dip i\u015faretleri veriyor.<\/p>\n<p><strong>Neden bu kadar a\u015f\u0131r\u0131 volatilite?<\/strong><\/p>\n<ul>\n<li>UnitedHealthcare GeneSight kapsam\u0131n\u0131 kesti (gelirin %20&#8217;si darbe ald\u0131)<\/li>\n<li>Menkul k\u0131ymetler doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 soru\u015fturmas\u0131 duyurusu<\/li>\n<li>Negatif nakit ak\u0131\u015f\u0131 endi\u015feleri<\/li>\n<li>Son 2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi umut \u0131\u015f\u0131\u011f\u0131 g\u00f6steriyor<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 8,00 $-11,00 $ \u2192 <strong>D\u0130KKATL\u0130 ALIM<\/strong><br \/> 3. ve 4. \u00e7eyrek iyile\u015fme g\u00f6sterirse, analist hedeflerine do\u011fru bir y\u00fckseli\u015f g\u00f6rebiliriz. Son kredi imkan\u0131 nefes ald\u0131r\u0131yor.<\/p>\n<p><strong>2026 Projeksiyonu<\/strong>: 12,00 $-18,00 $<br \/> Onkoloji geni\u015flemesinin ba\u015far\u0131l\u0131 olmas\u0131 ve yasal sorunlar\u0131n \u00e7\u00f6z\u00fclmesi durumunda \u0131l\u0131ml\u0131 bir toparlanma m\u00fcmk\u00fcn g\u00f6r\u00fcn\u00fcyor.<\/p>\n<p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 15,00 $-25,00 $<br \/> Uzun vadede kanser testi benimsenmesi ve yeni \u00fcr\u00fcn lansmanlar\u0131na ba\u011fl\u0131. Hassas t\u0131p pazar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde b\u00fcy\u00fcmeli.<\/p>\n<p><strong>2030 Vizyonu<\/strong>: 20,00 $-30,00 $<br \/> Myriad kal\u0131tsal kanser testlerinde lider olur ve uluslararas\u0131 alanda geni\u015flerse, \u00f6nemli bir yukar\u0131 potansiyel var.<\/p>\n<p><strong>Karar<\/strong>: Sadece risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in. Mevcut fiyat potansiyel y\u00fckseli\u015f sunuyor, ancak bir\u00e7ok zorluk devam ediyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon kabusu<\/strong>: UnitedHealthcare kapsam kesintileri di\u011fer sigortac\u0131lara yay\u0131labilir<\/li>\n<li><strong>Mali stres<\/strong>: Negatif i\u015fletme nakit ak\u0131\u015f\u0131 (son \u00e7eyrekte 16,3 milyon $) ve devam eden zararlar<\/li>\n<li><strong>Hukuki belirsizlik<\/strong>: Menkul k\u0131ymetler doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 soru\u015fturmas\u0131 belirsizlik ve potansiyel y\u00fck\u00fcml\u00fcl\u00fckler yarat\u0131yor<\/li>\n<li><strong>A\u015f\u0131r\u0131 volatilite<\/strong>: G\u00fcnl\u00fck %6,44 dalgalanmalar sinirli yat\u0131r\u0131mc\u0131lar i\u00e7in uygun de\u011fil<\/li>\n<li><strong>Rekabet<\/strong>: Daha iyi teknolojiye sahip yeni genetik test \u015firketleri ortaya \u00e7\u0131k\u0131yor<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi<\/strong>: 213,1 milyon $ gelir tahminleri %5,6 a\u015ft\u0131 (<a href=\"https:\/\/www.nasdaq.com\/articles\/myriad-genetics-mygn-q2-revenue-6\">Nasdaq Raporu<\/a>)<\/li>\n<li><strong>Yeni 200 milyon $ kredi imkan\u0131<\/strong>: Kritik finansal esneklik sa\u011fl\u0131yor (<a href=\"https:\/\/investor.myriad.com\/news-releases\/news-release-detail\/26541\/\">\u015eirket Duyurusu<\/a>)<\/li>\n<li><strong>Br\u00fct kar marj\u0131 geni\u015flemesi<\/strong>: %71,2&#8217;ye y\u00fckselerek operasyonel verimlilik g\u00f6steriyor<\/li>\n<li><strong>Kanser testi geni\u015flemesi<\/strong>: MyRisk kal\u0131tsal kanser testi ilgi g\u00f6r\u00fcyor<\/li>\n<li><strong>EMR entegrasyonu<\/strong>: Epic ve Flatiron sistemleri ile \u00e7al\u0131\u015f\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Kas\u0131m kazan\u00e7lar\u0131n\u0131 bekleyin<\/strong>: 6 Kas\u0131m raporu netlik sa\u011flayacak\u2014k\u00f6r\u00fc k\u00f6r\u00fcne atlamay\u0131n<\/li>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Al\u0131m yaparsan\u0131z, portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3&#8217;\u00fcnden fazlas\u0131n\u0131 bu y\u00fcksek riskli i\u015fe ay\u0131rmay\u0131n<\/li>\n<li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong>: Bu hisse dramatik d\u00fc\u015f\u00fc\u015fler yapabilir\u2014sermayenizi koruyun<\/li>\n<li><strong>\u00c7e\u015fitlendirin<\/strong>: T\u00fcm biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131z\u0131 tek sepete koymay\u0131n<\/li>\n<\/ol>\n<p><strong>Mizahi not<\/strong>: &#8220;MYGN ticareti genetik test gibi\u2014bazen beklenmedik \u00f6zellikler ke\u015ffedersiniz&#8230; mesela hesab\u0131n\u0131z\u0131n ne kadar h\u0131zl\u0131 a\u015fa\u011f\u0131 mutasyona u\u011frayabilece\u011fi!&#8221;<\/p>\n<h2>\u2705 Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ hisselerini sunan ve rekabet\u00e7i \u00fccretlere sahip oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Risk edebilece\u011finiz k\u00fc\u00e7\u00fck bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>MYGN&#8217;yi kapsaml\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>Sadece g\u00fcncel fiyat\u0131n \u00f6tesindeki riskleri anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit emirleri kullan\u0131n<\/td>\n<td>A\u015f\u0131r\u0131 \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Pozisyonu yak\u0131ndan takip edin<\/td>\n<td>Bu hisse aktif y\u00f6netim gerektirir, unutup b\u0131rakmak uygun de\u011fil<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option MYGN Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>Myriad Genetics, Inc. (MYGN) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 d\u00fc\u015f\u00fcnenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; MYGN gibi y\u00fcksek riskli hisselerle strateji test etmek i\u00e7in ideal<\/li>\n<li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> &#8211; F\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda h\u0131zl\u0131ca ticarete ba\u015flay\u0131n<\/li>\n<li><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; Kar almay\u0131 veya zarar\u0131 h\u0131zl\u0131 kesmeyi esnek hale getirir<\/li>\n<li><strong>Ger\u00e7ek zamanl\u0131 NASDAQ verisi<\/strong> &#8211; Volatil biyoteknoloji hisselerinin zamanlamas\u0131 i\u00e7in vazge\u00e7ilmez<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, b\u00fcy\u00fck sermaye taahh\u00fct etmeden MYGN gibi spek\u00fclatif hisselere maruz kalmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Myriad Genetics: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Myriad Genetics, sa\u011fl\u0131k inovasyonu ile finansal zorluklar\u0131n kesi\u015fim noktas\u0131nda duruyor. \u015eirket, kanser risklerini tespit etmeye ve tedavi kararlar\u0131n\u0131 y\u00f6nlendirmeye yard\u0131mc\u0131 olan molek\u00fcler tan\u0131 testlerinde uzmanla\u015fm\u0131\u015ft\u0131r ve bir\u00e7ok t\u0131bbi uzmanl\u0131k alan\u0131nda hizmet vermektedir.<\/p>\n<p><strong>Mevcut Pazar Konumu<\/strong>: Son zorluklara ra\u011fmen, Myriad genetik testlerde \u00f6nemli bir oyuncu olmaya devam ediyor:<\/p>\n<ul>\n<li>\u00d6nde gelen kal\u0131tsal kanser risk de\u011ferlendirme teknolojisi<\/li>\n<li>B\u00fcy\u00fcyen prenatal test segmenti (son \u00e7eyrekte %11 art\u0131\u015f)<\/li>\n<li>Geni\u015fleyen elektronik t\u0131bbi kay\u0131t entegrasyonu<\/li>\n<li>200 milyon $ kredi imkan\u0131 ile operasyonel s\u00fcreklilik<\/li>\n<\/ul>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Myriad&#8217;nin SneakPeek Erken Cinsiyet DNA Testi yak\u0131n zamanda <strong>bir milyonuncu m\u00fc\u015fterisine<\/strong> sonu\u00e7 verdi\u2014sa\u011fl\u0131k geri \u00f6deme zorluklar\u0131na ra\u011fmen genetik i\u00e7g\u00f6r\u00fclere olan t\u00fcketici talebinin b\u00fcy\u00fcmeye devam etti\u011fini kan\u0131tl\u0131yor.<\/p>\n"},"faq":[{"question":"Myriad Genetics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, MYGN hakk\u0131nda ara\u015ft\u0131rma yap\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve pozisyonunuzu yak\u0131ndan takip edin."},{"question":"MYGN hissesinin riskleri nelerdir?","answer":"Reg\u00fclasyon de\u011fi\u015fiklikleri, finansal stres, hukuki soru\u015fturmalar, y\u00fcksek volatilite ve artan rekabet MYGN i\u00e7in ba\u015fl\u0131ca risklerdir."},{"question":"MYGN hissesi i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 8-11 $, 2026'da 12-18 $, 2028'de 15-25 $ ve 2030'da 20-30 $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar MYGN hissesi al\u0131rken nelere dikkat etmeli?","answer":"Kas\u0131m kazan\u00e7 raporunu beklemek, k\u00fc\u00e7\u00fck yat\u0131r\u0131mlarla ba\u015flamak, s\u0131k\u0131 stop-loss kullanmak ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek \u00f6nemlidir."},{"question":"Pocket Option MYGN yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve ger\u00e7ek zamanl\u0131 NASDAQ verisi sunarak MYGN gibi volatil hisseler i\u00e7in ideal bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Myriad Genetics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, MYGN hakk\u0131nda ara\u015ft\u0131rma yap\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve pozisyonunuzu yak\u0131ndan takip edin."},{"question":"MYGN hissesinin riskleri nelerdir?","answer":"Reg\u00fclasyon de\u011fi\u015fiklikleri, finansal stres, hukuki soru\u015fturmalar, y\u00fcksek volatilite ve artan rekabet MYGN i\u00e7in ba\u015fl\u0131ca risklerdir."},{"question":"MYGN hissesi i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 8-11 $, 2026'da 12-18 $, 2028'de 15-25 $ ve 2030'da 20-30 $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar MYGN hissesi al\u0131rken nelere dikkat etmeli?","answer":"Kas\u0131m kazan\u00e7 raporunu beklemek, k\u00fc\u00e7\u00fck yat\u0131r\u0131mlarla ba\u015flamak, s\u0131k\u0131 stop-loss kullanmak ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek \u00f6nemlidir."},{"question":"Pocket Option MYGN yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve ger\u00e7ek zamanl\u0131 NASDAQ verisi sunarak MYGN gibi volatil hisseler i\u00e7in ideal bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T12:03:42+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T12:03:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/\",\"name\":\"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-28T12:03:42+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/","og_locale":"tr_TR","og_type":"article","og_title":"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T12:03:42+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T12:03:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/","name":"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-28T12:03:42+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-myriad-genetics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Myriad Genetics, Inc. (MYGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Myriad Genetics, Inc. (MYGN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":354472,"slug":"how-to-buy-myriad-genetics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Myriad Genetics, Inc. (MYGN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Myriad Genetics, Inc. (MYGN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-myriad-genetics\/"},"pt_AA":{"locale":"pt_AA","id":354474,"slug":"how-to-buy-myriad-genetics","post_title":"Como comprar a\u00e7\u00f5es da Myriad Genetics, Inc. (MYGN) - Investimento em a\u00e7\u00f5es da Myriad Genetics, Inc. (MYGN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-myriad-genetics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=354471"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354471\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=354471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=354471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=354471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}